LXRX
LEXICON PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.48
−0.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 50.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.77x
- Price / sales
- 15.88x
- Price / cash flow
- -8.26x
Enterprise value
- Enterprise value
- $527.2M
- EV / sales
- 12.71x
- EV / EBITDA
- -10.09x
- EV / EBIT
- -9.67x
- Market cap
- $658.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026